COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease.
Kofi ClarkeMatthew PeltonAugust StuartAndrew TinsleyShannon DalessioNana BernaskoEmmanuelle D WilliamsMatthew CoatesPublished in: Digestive diseases and sciences (2022)
Over one-third of patients with IBD expressed COVID-19 vaccine hesitancy. Vaccine safety and efficacy were the most common reasons. Younger age, previous vaccine refusal and earlier date of survey were more likely to be associated with hesitancy. Our findings suggest that there is room for targeted education to improve COVID-19 vaccine uptake in patients with IBD.